Price Alert

Pacific Biosciences of Ca... (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.27

0.03 (2.42%)

At close: Sep 05, 2025, 3:59 PM

1.25

-1.57%

After-hours: Sep 05, 2025, 07:49 PM EDT

Pacific Biosciences of California Statistics

Share Statistics

Pacific Biosciences of California has 300.37M shares outstanding. The number of shares has increased by 10.11% in one year.

Shares Outstanding	300.37M
Shares Change (YoY)	10.11%
Shares Change (QoQ)	0.75%
Owned by Institutions (%)	75.83%
Shares Floating	264.44M
Failed to Deliver (FTD) Shares	58,453
FTD / Avg. Volume	0.7%

Short Selling Information

The latest short interest is 42.17M, so 14.04% of the outstanding shares have been sold short.

Short Interest	42.17M
Short % of Shares Out	14.04%
Short % of Float	15.97%
Short Ratio (days to cover)	4.44

Valuation Ratios

The PE ratio is -1.62 and the forward PE ratio is -2.38. Pacific Biosciences of California's PEG ratio is 0.25.

PE Ratio	-1.62
Forward PE	-2.38
PS Ratio	3.26
Forward PS	2
PB Ratio	0.99
P/FCF Ratio	-2.37
PEG Ratio	0.25

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pacific Biosciences of California.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.48, with a Debt / Equity ratio of 1.33.

Current Ratio	7.48
Quick Ratio	6.59
Debt / Equity	1.33
Debt / EBITDA	-2.77
Debt / FCF	-3.17
Interest Coverage	-35.36

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$267.85K
Profits Per Employee	$-538.87K
Employee Count	575
Asset Turnover	0.12
Inventory Turnover	1.99

Taxes

Income Tax	316K
Effective Tax Rate	-0.1%

Stock Price Statistics

The stock price has increased by -19.62% in the last 52 weeks. The beta is 1.87, so Pacific Biosciences of California's price volatility has been higher than the market average.

Beta	1.87
52-Week Price Change	-19.62%
50-Day Moving Average	1.39
200-Day Moving Average	1.44
Relative Strength Index (RSI)	45.49
Average Volume (20 Days)	8,369,354

Income Statement

In the last 12 months, Pacific Biosciences of California had revenue of 154.01M and earned -309.85M in profits. Earnings per share was -1.13.

Revenue	154.01M
Gross Profit	37.28M
Operating Income	-474.31M
Net Income	-309.85M
EBITDA	-242.78M
EBIT	-296.12M
Earnings Per Share (EPS)	-1.13

Full Income Statement

Balance Sheet

The company has 55.37M in cash and 672.43M in debt, giving a net cash position of -617.06M.

Cash & Cash Equivalents	55.37M
Total Debt	672.43M
Net Cash	-617.06M
Retained Earnings	-2.15B
Total Assets	825.47M
Working Capital	353.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -206.06M and capital expenditures -6.19M, giving a free cash flow of -212.25M.

Operating Cash Flow	-206.06M
Capital Expenditures	-6.19M
Free Cash Flow	-212.25M
FCF Per Share	-0.77

Full Cash Flow Statement

Margins

Gross margin is 24.21%, with operating and profit margins of -307.97% and -201.18%.

Gross Margin	24.21%
Operating Margin	-307.97%
Pretax Margin	-200.98%
Profit Margin	-201.18%
EBITDA Margin	-157.64%
EBIT Margin	-307.97%
FCF Margin	-137.81%

Dividends & Yields

PACB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for PACB is $1.65, which is 29.9% higher than the current price. The consensus rating is "Hold".

Price Target	$1.65
Price Target Difference	29.9%
Analyst Consensus	Hold
Analyst Count	7

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-5.5
Piotroski F-Score	4